These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 28765250)

  • 21. Validation of OMERACT preliminary rheumatoid arthritis flare domains in the NOR-DMARD study.
    Lie E; Woodworth TG; Christensen R; Kvien TK; Bykerk V; Furst DE; Bingham CO; Choy EH;
    Ann Rheum Dis; 2014 Oct; 73(10):1781-7. PubMed ID: 23852690
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative Assessment of the Different American College of Rheumatology/European League Against Rheumatism Remission Definitions for Rheumatoid Arthritis for Their Use as Clinical Trial End Points.
    Mack ME; Hsia E; Aletaha D
    Arthritis Rheumatol; 2017 Mar; 69(3):518-528. PubMed ID: 27696724
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Validity and reliability problems with patient global as a component of the ACR/EULAR remission criteria as used in clinical practice.
    Masri KR; Shaver TS; Shahouri SH; Wang S; Anderson JD; Busch RE; Michaud K; Mikuls TR; Caplan L; Wolfe F
    J Rheumatol; 2012 Jun; 39(6):1139-45. PubMed ID: 22589262
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Responsiveness in rheumatoid arthritis. a report from the OMERACT 11 ultrasound workshop.
    Iagnocco A; Naredo E; Wakefield R; Bruyn GA; Collado P; Jousse-Joulin S; Finzel S; Ohrndorf S; Delle Sedie A; Backhaus M; Berner-Hammer H; Gandjbakhch F; Kaeley G; Loeuille D; Moller I; Terslev L; Aegerter P; Aydin S; Balint PV; Filippucci E; Mandl P; Pineda C; Roth J; Magni-Manzoni S; Tzaribachev N; Schmidt WA; Conaghan PG; D'Agostino MA
    J Rheumatol; 2014 Feb; 41(2):379-82. PubMed ID: 24241482
    [TBL] [Abstract][Full Text] [Related]  

  • 25. OMERACT 10 Patient Perspective Virtual Campus: valuing health; measuring outcomes in rheumatoid arthritis fatigue, RA sleep, arthroplasty, and systemic sclerosis; and clinical significance of changes in health.
    Kirwan JR; Boonen A; Harrison MJ; Hewlett SE; Wells GA; Singh JA; Furst DE; Dworkin RH
    J Rheumatol; 2011 Aug; 38(8):1728-34. PubMed ID: 21807793
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identifying flares in rheumatoid arthritis: reliability and construct validation of the OMERACT RA Flare Core Domain Set.
    Bykerk VP; Bingham CO; Choy EH; Lin D; Alten R; Christensen R; Furst DE; Hewlett S; Leong A; March L; Woodworth T; Boire G; Haraoui B; Hitchon C; Jamal S; Keystone EC; Pope J; Tin D; Thorne JC; Bartlett SJ
    RMD Open; 2016; 2(1):e000225. PubMed ID: 27252895
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overview of the patient perspective at OMERACT 10--conceptualizing methods for developing patient-reported outcomes.
    Kirwan JR; Tugwell PS
    J Rheumatol; 2011 Aug; 38(8):1699-701. PubMed ID: 21807788
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stiffness Is the Cardinal Symptom of Inflammatory Musculoskeletal Diseases, Yet Still Variably Measured: Report from the OMERACT 2016 Stiffness Special Interest Group.
    Halls S; Sinnathurai P; Hewlett S; Mackie SL; March L; Bartlett SJ; Bingham CO; Alten R; Campbell I; Hill CL; Holt RJ; Hughes R; Kirwan JR; Leong AL; Leung YY; Lyddiatt A; Neill L; Orbai AM
    J Rheumatol; 2017 Dec; 44(12):1904-1910. PubMed ID: 27980014
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patient perspective: choosing or developing instruments.
    Kirwan JR; Fries JF; Hewlett S; Osborne RH
    J Rheumatol; 2011 Aug; 38(8):1716-9. PubMed ID: 21807791
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The patient perspective on remission in rheumatoid arthritis: 'You've got limits, but you're back to being you again'.
    van Tuyl LH; Hewlett S; Sadlonova M; Davis B; Flurey C; Hoogland W; Kirwan J; Sanderson T; van Schaardenburg D; Scholte-Voshaar M; Smolen J; Stamm T; Boers M
    Ann Rheum Dis; 2015 Jun; 74(6):1004-10. PubMed ID: 24521737
    [TBL] [Abstract][Full Text] [Related]  

  • 31. American College of Rheumatology/European League Against Rheumatism remission criteria for rheumatoid arthritis maintain reliable performance when evaluated in 44 joints.
    Kaneko Y; Kondo H; Takeuchi T
    J Rheumatol; 2013 Aug; 40(8):1254-8. PubMed ID: 23772077
    [TBL] [Abstract][Full Text] [Related]  

  • 32. American College of Rheumatology/European League against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials.
    Felson DT; Smolen JS; Wells G; Zhang B; van Tuyl LH; Funovits J; Aletaha D; Allaart CF; Bathon J; Bombardieri S; Brooks P; Brown A; Matucci-Cerinic M; Choi H; Combe B; de Wit M; Dougados M; Emery P; Furst D; Gomez-Reino J; Hawker G; Keystone E; Khanna D; Kirwan J; Kvien TK; Landewé R; Listing J; Michaud K; Martin-Mola E; Montie P; Pincus T; Richards P; Siegel JN; Simon LS; Sokka T; Strand V; Tugwell P; Tyndall A; van der Heijde D; Verstappen S; White B; Wolfe F; Zink A; Boers M
    Ann Rheum Dis; 2011 Mar; 70(3):404-13. PubMed ID: 21292833
    [TBL] [Abstract][Full Text] [Related]  

  • 33. How to choose core outcome measurement sets for clinical trials: OMERACT 11 approves filter 2.0.
    Boers M; Kirwan JR; Gossec L; Conaghan PG; D'Agostino MA; Bingham CO; Brooks PM; Landewé R; March L; Simon L; Singh JA; Strand V; Wells GA; Tugwell P
    J Rheumatol; 2014 May; 41(5):1025-30. PubMed ID: 24584913
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Minimal disease activity, remission, and the long-term outcomes of rheumatoid arthritis.
    Wolfe F; Rasker JJ; Boers M; Wells GA; Michaud K
    Arthritis Rheum; 2007 Aug; 57(6):935-42. PubMed ID: 17665487
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of depression, anxiety, fatigue, and fibromyalgia on the evaluation of the remission status in patients with rheumatoid arthritis.
    Inanc N; Yilmaz-Oner S; Can M; Sokka T; Direskeneli H
    J Rheumatol; 2014 Sep; 41(9):1755-60. PubMed ID: 25086073
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Preliminary Core Domain Set for Clinical Trials of Shoulder Disorders: A Report from the OMERACT 2016 Shoulder Core Outcome Set Special Interest Group.
    Buchbinder R; Page MJ; Huang H; Verhagen AP; Beaton D; Kopkow C; Lenza M; Jain NB; Richards B; Richards P; Voshaar M; van der Windt D; Gagnier JJ;
    J Rheumatol; 2017 Dec; 44(12):1880-1883. PubMed ID: 28089972
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Worker productivity outcome measures: OMERACT filter evidence and agenda for future research.
    Tang K; Boonen A; Verstappen SM; Escorpizo R; Luime JJ; Lacaille D; Fautrel B; Bosworth A; Cifaldi M; Gignac MA; Hofstetter C; Leong A; Montie P; Petersson IF; Purcaru O; Bombardier C; Tugwell PS; Beaton DE
    J Rheumatol; 2014 Jan; 41(1):165-76. PubMed ID: 24128774
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MRI of rheumatoid arthritis:comparing the outcome measures in rheumatology clinical trials (OMERACT) scoring and volume of synovitis for the assessment of biologic therapy.
    Nakahara R; Nishida K; Hashizume K; Harada R; Machida T; Horita M; Ohtsuka A; Ozaki T
    Acta Med Okayama; 2015; 69(1):29-35. PubMed ID: 25703168
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Performance of the 2011 ACR/EULAR preliminary remission criteria compared with DAS28 remission in unselected patients with rheumatoid arthritis.
    Thiele K; Huscher D; Bischoff S; Späthling-Mestekemper S; Backhaus M; Aringer M; Kohlmann T; Zink A;
    Ann Rheum Dis; 2013 Jul; 72(7):1194-9. PubMed ID: 22915625
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Developing a construct to evaluate flares in rheumatoid arthritis: a conceptual report of the OMERACT RA Flare Definition Working Group.
    Alten R; Pohl C; Choy EH; Christensen R; Furst DE; Hewlett SE; Leong A; May JE; Sanderson TC; Strand V; Woodworth TG; Bingham CO;
    J Rheumatol; 2011 Aug; 38(8):1745-50. PubMed ID: 21807796
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.